4//SEC Filing
Campbell Wendy Pizarro 4
Accession 0001493152-24-024598
CIK 0001855485other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 8:56 PM ET
Size
51.3 KB
Accession
0001493152-24-024598
Insider Transaction Report
Form 4
Campbell Wendy Pizarro
CAO, CLO
Transactions
- Award
Stock Options (right to buy)
2024-06-17+60,000→ 60,000 totalExercise: $0.20Exp: 2034-06-17→ Common stock (60,000 underlying) - Award
Stock Options (right to buy)
2024-06-17+40,000→ 40,000 totalExercise: $0.20Exp: 2034-06-17→ Common stock (40,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Issuer's 2023 Equity Incentive Plan (the "2023 Plan"), on June 17, 2024 (the "Grant Date"), the Reporting Person was granted 40,000 incentive stock options at an exercise price of $0.195, which is equal to the closing price of the Issuer's common stock on the Grant Date. The Options shall vest in 1/48th installments on the last day of each monthly period of the Reporting Person's continued service to the Issuer, commencing on 1/1/2024. The options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person.
- [F2]Pursuant to the Issuer's 2023 Plan, on the Grant Date, the Reporting Person was granted 60,000 Options at an exercise price of $0.195, which is equal to the closing price of the Issuer's common stock on the Grant Date. The Options shall vest in 1/48th installments on the last day of each monthly period of the Reporting Person's continued service to the Issuer, commencing on 5/13/2024. The options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person.
Documents
Issuer
Calidi Biotherapeutics, Inc.
CIK 0001855485
Entity typeother
Related Parties
1- filerCIK 0001990445
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 8:56 PM ET
- Size
- 51.3 KB